Rare blood disorder registry for histiocytic conditions
Part of Blood & lymphatic, Hormones & metabolism, Skin clinical trials.
This study is a registry that collects information about people diagnosed with rare histiocytic disorders. It helps doctors better understand these conditions over time and may improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your parent/legal guardian) must be able to sign informed consent
- You must have a rare histiocytic disorder diagnosis
- The diagnosis must be from 1995 or later
- You can join if you were diagnosed at any age
- If the patient cannot consent, a legal guardian can consent for them
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking in over time with people who have a histiocytic disorder. It may help doctors better understand how these conditions behave and what follow-up care works best.
This registry collects health information from people with HHT over time to better understand the disease and improve care. Joining does not involve any experimental treatment, but your data will help researchers learn more about HHT.
This study is building a registry of people with rare blood diseases. By joining, you help doctors learn more about these conditions and improve future care.
This is a registry (a research database) for people with Erdheim-Chester disease and other related “histiocytosis” conditions. It collects past and future medical information to better understand these illnesses and support future research.
This study is creating a European registry (database) to collect information about people with rare anemia disorders. By joining, you help researchers better understand these conditions and improve care for yourself and others.
This study is a disease registry that collects medical information from children who have hemophagocytic lymphohistiocytosis (HLH) or are suspected to have it. It helps doctors better understand HLH and how it affects patients over time.
Hear when a new Rare Histiocytic Disorders (RHDs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.